Rockefeller University-ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2024

  1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

    Human Genetics and Genomics Advances, Vol. 5, Núm. 3

2023

  1. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced Seroreactivity

    Molecular Therapy - Methods and Clinical Development, Vol. 19, pp. 347-361

2018

  1. Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency

    Journal of Clinical Immunology, Vol. 38, Núm. 4, pp. 513-526

2017

  1. CREBBP inactivation promotes the development of HDAC3-dependent lymphomas

    Cancer Discovery, Vol. 7, Núm. 1, pp. 38-53

  2. Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer

    Cancer Discovery, Vol. 7, Núm. 12, pp. 1420-1435

  3. Iron affects Ire1 clustering propensity and the amplitude of endoplasmic reticulum stress signaling

    Journal of Cell Science, Vol. 130, Núm. 19, pp. 3222-3233

2014

  1. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum

    Infection and Immunity, Vol. 82, Núm. 2, pp. 808-817

2012

  1. MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo

    Cancer Cell, Vol. 22, Núm. 6, pp. 812-824

2002

  1. Disseminated candidiasis and hepatic malarial infection in mannose-binding-lectin-A-deficient mice

    Molecular and Cellular Biology, Vol. 22, Núm. 23, pp. 8199-8203

2000

  1. Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production

    Journal of Experimental Medicine, Vol. 191, Núm. 12, pp. 2113-2120